Macrophages and liposomes in inflammatory disease: Friends or foes?

International Journal of Pharmaceutics

Volumn 416, Issue 2, 2011, Pages 499-506

  Crielaard, B J ^a   Lammers, T ^a,b   Morgan, M E ^a   Chaabane, L ^c   Carboni, S ^c   Greco, B ^c   Zaratin, P ^d   Kraneveld, A D ^a   Storm, G ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c MERCK SERONO S A   (Switzerland)

^d FISM Onlus AISM   (Italy)

Author keywords

Corticosteroids; Crohn's disease; Inflammatory disease; Liposomes; Macrophages; Multiple sclerosis

Indexed keywords

DEXAMETHASONE SODIUM PHOSPHATE; DEXTRAN SULFATE; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE MODEL; DRUG EFFICACY; FEMALE; LIPOSOMAL DELIVERY; MACROPHAGE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ANIMALS; COLITIS; CROHN DISEASE; DEXAMETHASONE; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GLUCOCORTICOIDS; INFLAMMATION; LIPOSOMES; MACROPHAGES; MICE; MULTIPLE SCLEROSIS;

EID: 80051895806     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.12.045     Document Type: Article

References (43)

1. T.M. Allen, C.B. Hansen, and D.E.L. de Menezes Pharmacokinetics of long-circulating liposomes Adv. Drug Deliv. Rev. 16 1995 267
2. N. Auphan, J.A. DiDonato, C. Rosette, A. Helmberg, and M. Karin Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis Science 270 1995 286 290
3. M. Banciu, J.M. Metselaar, R.M. Schiffelers, and G. Storm Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue Neoplasia 10 2008 108 117 (Pubitemid 351240876)
4. E. Benchimol, C. Seow, A. Steinhart, and A. Griffiths Traditional corticosteroids for induction of remission in Crohn's disease Cochrane Database Syst. Rev. 2008 Art. No.: CD006792
5. E. Bernasconi, L. Favre, M.H. Maillard, D. Bachmann, C. Pythoud, H. Bouzourene, E. Croze, S. Velichko, J. Parkinson, P. Michetti, and D. Velin Granulocyte-macrophage colony-stimulating factor elicits bone marrow-derived cells that promote efficient colonic mucosal healing Inflamm. Bowel Dis. 16 2010 428 441
6. E. Bligh, and W. Dyer A rapid method of total lipid extraction and purification Can. J. Biochem. Physiol. 37 1959 911 917
7. F. Brennan, R. Maini, and M. Feldmann Role of pro-inflammatory cytokines in rheumatoid arthritis Springer Semin. Immunopathol. 20 1998 133 147 (Pubitemid 28502453)
8. J.R.F. Cummings, S. Keshav, and S.P.L. Travis Medical management of Crohn's disease BMJ 336 2008 1062 1066 (Pubitemid 351692250)
9. J.P. Edwards, X. Zhang, K.A. Frauwirth, and D.M. Mosser Biochemical and functional characterization of three activated macrophage populations J. Leukoc. Biol. 80 2006 1298 1307 (Pubitemid 44904968)
10. J. Ehrchen, L. Steinmuller, K. Barczyk, K. Tenbrock, W. Nacken, M. Eisenacher, U. Nordhues, C. Sorg, C. Sunderkotter, and J. Roth Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes Blood 109 2007 1265 1274 (Pubitemid 46220679)
11. I.J. Elenkov Glucocorticoids and the Th1/Th2 balance Ann. N. Y. Acad. Sci. 1024 2004 138 146 (Pubitemid 38879598)
12. D.B. Fenske, and P.R. Cullis Liposomal nanomedicines Expert Opin. Drug. Deliv. 5 2008 25 44 (Pubitemid 351234108)
13. A. Gilman, and L. Goodman Goodman & Gilman's The Pharmacological Basis of Therapeutics 11th (Digital) ed. 2006 The McGraw-Hill Companies Inc New York
14. C.K. Glass, and K. Saijo Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells Nat. Rev. Immunol. 10 2010 365 376
15. R. Gold, C. Linington, and H. Lassmann Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research Brain 129 2006 1953 1971 (Pubitemid 44289062)
16. S. Gordon, and P.R. Taylor Monocyte and macrophage heterogeneity Nat. Rev. Immunol. 5 2005 953 964 (Pubitemid 41746764)
17. C. Grossmann, T. Scholz, M. Rochel, C. Bumke-Vogt, W. Oelkers, A.F. Pfeiffer, S. Diederich, and V. Bahr Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties Eur. J. Endocrinol. 151 2004 397 406 (Pubitemid 39307329)
18. S.E.M. Heinsbroek, and S. Gordon The role of macrophages in inflammatory bowel diseases Expert Rev. Mol. Med. 11 2009 e14
19. M.J. Hsu, and R.L. Juliano Interactions of liposomes with the reticuloendothelial system: II. Nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages BBA-Mol. Cell. Res. 720 1982 411
20. S.K. Huang, K.D. Lee, K. Hong, D.S. Friend, and D. Papahadjopoulos Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice Cancer Res. 52 1992 5135 5143
21. T.J. Imler Jr., and T.M. Petro Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17 + IL-10+ T cells CD4- IFN-[gamma]+ cells, and decreased macrophage IL-6 expression Int. Immunopharmacol. 9 2009 134 143
22. R.A. Linker, C. Weller, F. Lühder, A. Mohr, J. Schmidt, M. Knauth, J.M. Metselaar, and R. Gold Liposomal glucocorticosteroids in treatment of chronic autoimmune demyelination: long-term protective effects and enhanced efficacy of methylprednisolone formulations Exp. Neurol. 211 2008 397
23. A. Mantovani, A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati The chemokine system in diverse forms of macrophage activation and polarization Trends Immunol. 25 2004 677 686 (Pubitemid 39457982)
24. F.O. Martinez, L. Helming, and S. Gordon Alternative activation of macrophages: an immunologic functional perspective Annu. Rev. Immunol. 27 2009 451 483
25. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46 1986 6387 6392 (Pubitemid 17221789)
26. J.M. Metselaar, M.H.M. Wauben, J.P.A. Wagenaar-Hilbers, O.C. Boerman, and G. Storm Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes Arthritis Rheum. 48 2003 2059 2066 (Pubitemid 36828702)
27. J. Mikita, N.g. Dubourdieu-Cassagno, M.S.A. Deloire, A. Vekris, M. Biran, G.r. Raffard, B. Brochet, M.-H.l.n. Canron, J.-M. Franconi, C. Boiziau, and K.G. Petry Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of Multiple Sclerosis. Amelioration of clinical status by M2 activated monocyte administration Mult. Scler 2010
28. D.M. Mosser, and J.P. Edwards Exploring the full spectrum of macrophage activation Nat. Rev. Immunol. 8 2008 958 969
29. I. Okayasu, S. Hatakeyama, Y. Masahiro, O. Toshifumi, Y. Inagaki, and R. Nakaya A Novel Method in the Induction of Reliable Experimental Acute and Chronic Ulcerative Colitis in Mice Gastroenterology 98 1990 694 702 (Pubitemid 20069706)
30. A.M. Platt, and A.M. Mowat Mucosal macrophages and the regulation of immune responses in the intestine Immunol. Lett. 119 2008 22 31
31. J.E. Qualls, A.M. Kaplan, N. van Rooijen, and D.A. Cohen Suppression of experimental colitis by intestinal mononuclear phagocytes J. Leukoc. Biol. 80 2006 802 815 (Pubitemid 44835899)
32. S.K. Sainathan, E.M. Hanna, Q. Gong, K.S. Bishnupuri, Q. Luo, M. Colonna, F.V. White, E. Croze, C. Houchen, S. Anant, and B.K. Dieckgraefe Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis Inflamm. Bowel Dis. 14 2008 88 99 (Pubitemid 351196873)
33. B.S. Sandanaraj, H.-U. Gremlich, R. Kneuer, J. Dawson, and S. Wacha Fluorescent nanoprobes as a biomarker for increased vascular permeability: implications in diagnosis and treatment of cancer and inflammation Bioconjug. Chem. 21 2010 93 101
34. R.M. Schiffelers, J.M. Metselaar, M.H.A.M. Fens, A.P.C.A. Janssen, G. Molema, and G. Storm Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice Neoplasia 7 2005 118 127 (Pubitemid 40315989)
35. J. Schmidt, J.M. Metselaar, M.H.M. Wauben, K.V. Toyka, G. Storm, and R. Gold Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis Brain 126 2003 1895 1904 (Pubitemid 36917348)
36. L.M. Schönrock, G. Gawlowski, and W. Brück Interleukin-6 expression in human multiple sclerosis lesions Neurosci. Lett. 294 2000 45 48
37. G. Storm, P.A. Steerenberg, F. Emmen, M. van Borssum Waalkes, and D.J.A. Crommelin Release of doxorubicin from peritoneal macrophages exposed in vivo to doxorubicin-containing liposomes BBA-Gen Subj. 965 1988 136
38. R.D. Stout, C. Jiang, B. Matta, I. Tietzel, S.K. Watkins, and J. Suttles Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences J. Immunol. 175 2005 342 349 (Pubitemid 40884337)
39. R.D. Stout, and J. Suttles Functional plasticity of macrophages: reversible adaptation to changing microenvironments J. Leukoc. Biol. 76 2004 509 513 (Pubitemid 39129080)
40. V.K. Tuohy, R.A. Sobel, and M.B. Lees Myelin proteolipid protein-induced experimental allergic encephalomyelitis. Variations of disease expression in different strains of mice J. Immunol. 140 1988 1868 1873
41. J.F. Valentine, R.N. Fedorak, B. Feagan, P. Fredlund, R. Schmitt, P. Ni, and T.J. Humphries Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, phase 2 study Gut 58 2009 1354 1362
42. N. van Rooijen, and E. van Kesteren-Hendrikx Clodronate liposomes: perspectives in research and therapeutics J. Liposome Res. 12 2002 81 94 (Pubitemid 34846960)
43. S. Wirtz, C. Neufert, B. Weigmann, and M.F. Neurath Chemically induced mouse models of intestinal inflammation Nat. Protoc. 2 2007 541